Human herpesviruses: biology, therapy, and immunoprophylaxis
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
Cambridge [u.a.]
Cambridge Univ. Press
2007
|
Ausgabe: | 1. publ. |
Schlagworte: | |
Online-Zugang: | Volltext Inhaltsverzeichnis Klappentext |
Beschreibung: | XX, 1388 S. Ill., graph. Darst. |
ISBN: | 0521827140 9780521827140 |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV021579848 | ||
003 | DE-604 | ||
005 | 20110209 | ||
007 | t | ||
008 | 060512s2007 ad|| |||| 00||| eng d | ||
020 | |a 0521827140 |9 0-521-82714-0 | ||
020 | |a 9780521827140 |9 978-0-521-82714-0 | ||
035 | |a (OCoLC)170026590 | ||
035 | |a (DE-599)BVBBV021579848 | ||
040 | |a DE-604 |b ger |e rakwb | ||
041 | 0 | |a eng | |
049 | |a DE-355 |a DE-29 | ||
050 | 0 | |a QR201.H48 | |
082 | 0 | |a 616.9112 |2 22 | |
084 | |a XD 7400 |0 (DE-625)152595:13129 |2 rvk | ||
245 | 1 | 0 | |a Human herpesviruses |b biology, therapy, and immunoprophylaxis |c ed. by Ann Arvin ... |
250 | |a 1. publ. | ||
264 | 1 | |a Cambridge [u.a.] |b Cambridge Univ. Press |c 2007 | |
300 | |a XX, 1388 S. |b Ill., graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
650 | 4 | |a Maladies à herpèsvirus | |
650 | 4 | |a Antiviral Agents | |
650 | 4 | |a Herpesviridae Infections | |
650 | 4 | |a Herpesvirus Vaccines | |
650 | 4 | |a Herpesvirus diseases | |
650 | 0 | 7 | |a Herpesviren |0 (DE-588)4159627-4 |2 gnd |9 rswk-swf |
689 | 0 | 0 | |a Herpesviren |0 (DE-588)4159627-4 |D s |
689 | 0 | |5 DE-604 | |
700 | 1 | |a Arvin, Ann M. |e Sonstige |4 oth | |
856 | 4 | 1 | |u http://www.ncbi.nlm.nih.gov/books/NBK47376/ |x Verlag |z kostenfrei |3 Volltext |
856 | 4 | 2 | |m Digitalisierung UB Regensburg |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014795525&sequence=000003&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
856 | 4 | 2 | |m Digitalisierung UB Regensburg |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014795525&sequence=000004&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA |3 Klappentext |
912 | |a ebook | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-014795525 |
Datensatz im Suchindex
_version_ | 1804135350890659840 |
---|---|
adam_text | Contents
List of contributors page
Preface
Part I Introduction: definition and
classification of the human herpesviruses
Bernard Roizman
1
Andrew Davison
2
Andrew Davison
3
herpesviruses
Fenyong Liu and Z. Hong Zhou
4
proteins
Edward Mocarski, Jr.
Part II Basic virology and viral gene effects on
host cell functions: alphaherpesviruses
Gabriella Campadelli-Fiume
5
alphaherpesvirus genomes
Joel Baines and Philip Pellett
6
Bernard Roizman and
7
Gabriella
VI
Contents
8
gene expression
Thomas Kristie
9
processing, and transport in
infected cells
Rozanne Sandri-Goldin
10
John Hay and William Ruyechan
11
inner nuclear membrane
Joel Baines
12
Gabriella Campadelli-Fiume
13
and takeover of the host cell
Bernard Roizman and
Part II Basic virology and viral gene effects on
host cell functions: betaherpesviruses
Edward Mocarski
14
virion structure
Andrew Davison and David Bhella
15
Edward Mocarski
16
infection
Teresa Compton and Adam
231
17
function
Mark Stinski and Jeffrey Meier
18
Elizabeth White and Deborah Spector
19
expression
David Anders, Juiie Kerry and Gregory
20
William Britt
21
infection
A. Louise McCormick and Edward Mocarski, jr.
Part II Basic virology and viral gene effects on
host cell functions: gammaherpesviruses
Patrick S. Moore
22
Richard Longnecker and Frank Neipel
23
during infection
Bala Chandran
24
replication during latency
Paul Lieberman, Jianhong
25
Shannon Kenney
26
David Lukac and Yan Yuan
27
Lawrence S. Young, John R. Arrand, and Paul G. Murray
28
Thomas
30
programmed cell death pathways
Patrick Moore
33 HSV-1
and reactivation
Christopher Preston and Stacey Efstathiou
490
29
transformation, and comparative aspects of
EBV with other
George Klein and
540
31
strategies
Robert Means,
Part III Pathogenesis, clinical disease, host
response, and epidemiology:
HSV-1 and HSV-2
Ann Arvin and Richard Whitley
32
Richard Whitley, David
602
Contents
VII
34 HSV-1
response
David
35 HSV: immunopathological
infection
Kaustuv Banerjee and Barry Rouse
36 HSV:
epidemiology, transmission
Anna
616
642
45
transplacental transmission
Lenore Peirera, Ekaterina Maidji, and Susan Fisher
Part III Pathogenesis, clinical disease, host
response, and epidemiology:
HHV- 6A, 6B, and
656
Part III Pathogenesis, clinical disease, host
response, and epidemiology:
VZU
Ann Arvin and Richard Whitley
37
consequences of primary infection
Jennifer Moffat, Chia-chi Ku, Leigh Zerboni, Marvin
Sommer,
38
and reactivation)
Jeffrey Cohen
39
Ann Arvin and Allison
40
transmission and epidemiology
Jane Seward and Aisha Jumaan
Part III Pathogenesis, clinical disease, host
response, and epidemiology:
HCMV
Ann Arvin and Richard Whitley
41
consequences
William
42
latency
Michael Jarvis and Jay Nelson
43
Mark Wills, Andrew Carmichael, J. H. Sinclair, and J. G.
Patrick Sissons
44
epidemiology and transmission
Suresh Boppana and Karen Fowler
46
response, and clinical disease
Yasuko Mori and Koichi Yamanishi
47
and reactivation
Kaszuhiro Kondo and Koichi Yamanishi
48
response
Fu-Zhang Wang and Philip Pellet
49
population: epidemiology, transmission
Vincent Emery and Duncan Clark
Part III Pathogenesis, clinical disease, host
response, and epidemiology:
gammaherpesviruses
713
50
KSHV infection
Richard
51
Denis Moss, Scott Burrows, and Rajiv Khanna
52
infection
Dimitrios Lagos and Chris Boshoff
53
with malignant disease
Henrik Hjalgrim,
54
with malignant disease
Jeffrey Martin
55
Nancy Raab-Traub
56
Donald
885
904
915
929
960
986
1007
VIII
Contents
Part IV Non-human primate herpesviruses
Ann Arvin, Patrick Moore, and Richard Whitley
57
Julia Hilliard
58
Ravi Mahalingam and Donald
59
Peter Barry and William Chang
60
Armin Ensser
61
non-human primates
Blossom Damania
Part V Subversion of adaptive immunity
Richard Whitley and Ann Arvin
62
Jatin Vyas, Benjamin
1117
63
immune evasion from antibody and
complement
Lauren Hook and Harvey Friedman
Part VI Antiviral therapy
Richard Whitley
64
David
65
infections
John Gnann, Jr.
66
cytomegalovirus
Paul Griffiths and Michael Boeckh
67
(genomics/proteomics)
Mark Prichard
1211
68
of action and resistance
Karen Biron
Part
Ann Arvin and Koichi Yamanishi
69
George Kemble and Richard Spaete
70
Anne Gershon
71
Thomas Heineman
72
Andrew Morgan and Rajiv Khanna
73 DNA
Thomas Evans and Mary Wloch
74
Ann M.
Rooney
75
delivery
David
Part
1175
76
Frank Tufaro and James
Index
1341
1353
This definitive and comprehensive account of the human
herpesviruses provides an encylopedic overview of their
basic virology and clinical manifestations. This group of
viruses includes human herpes simplex virus type
2.
herpesvirus. cytomegalovirus. varicella-zoster virus, and
human herpesviruses
The diseases they cause are significant and often
recurrent. Their prevalence in the developed world
accounts for a major burden of disease, and as a result
there is a great deal of research into the pathophysiology
of infection and immunobiology.
Another important area covered within this volume
concerns antiviral therapy and the development of
vaccines. All these aspects are covered in depth both
scientifically and in terms of clinical guidelines for
patient care. The text is generously illustrated
throughout and fully referenced to the latest research
and developments.
|
adam_txt |
Contents
List of contributors page
Preface
Part I Introduction: definition and
classification of the human herpesviruses
Bernard Roizman
1
Andrew Davison
2
Andrew Davison
3
herpesviruses
Fenyong Liu and Z. Hong Zhou
4
proteins
Edward Mocarski, Jr.
Part II Basic virology and viral gene effects on
host cell functions: alphaherpesviruses
Gabriella Campadelli-Fiume
5
alphaherpesvirus genomes
Joel Baines and Philip Pellett
6
Bernard Roizman and
7
Gabriella
VI
Contents
8
gene expression
Thomas Kristie
9
processing, and transport in
infected cells
Rozanne Sandri-Goldin
10
John Hay and William Ruyechan
11
inner nuclear membrane
Joel Baines
12
Gabriella Campadelli-Fiume
13
and takeover of the host cell
Bernard Roizman and
Part II Basic virology and viral gene effects on
host cell functions: betaherpesviruses
Edward Mocarski
14
virion structure
Andrew Davison and David Bhella
15
Edward Mocarski
16
infection
Teresa Compton and Adam
231
17
function
Mark Stinski and Jeffrey Meier
18
Elizabeth White and Deborah Spector
19
expression
David Anders, Juiie Kerry and Gregory
20
William Britt
21
infection
A. Louise McCormick and Edward Mocarski, jr.
Part II Basic virology and viral gene effects on
host cell functions: gammaherpesviruses
Patrick S. Moore
22
Richard Longnecker and Frank Neipel
23
during infection
Bala Chandran
24
replication during latency
Paul Lieberman, Jianhong
25
Shannon Kenney
26
David Lukac and Yan Yuan
27
Lawrence S. Young, John R. Arrand, and Paul G. Murray
28
Thomas
30
programmed cell death pathways
Patrick Moore
33 HSV-1
and reactivation
Christopher Preston and Stacey Efstathiou
490
29
transformation, and comparative aspects of
EBV with other
George Klein and
540
31
strategies
Robert Means,
Part III Pathogenesis, clinical disease, host
response, and epidemiology:
HSV-1 and HSV-2
Ann Arvin and Richard Whitley
32
Richard Whitley, David
602
Contents
VII
34 HSV-1
response
David
35 HSV: immunopathological
infection
Kaustuv Banerjee and Barry Rouse
36 HSV:
epidemiology, transmission
Anna
616
642
45
transplacental transmission
Lenore Peirera, Ekaterina Maidji, and Susan Fisher
Part III Pathogenesis, clinical disease, host
response, and epidemiology:
HHV- 6A, 6B, and
656
Part III Pathogenesis, clinical disease, host
response, and epidemiology:
VZU
Ann Arvin and Richard Whitley
37
consequences of primary infection
Jennifer Moffat, Chia-chi Ku, Leigh Zerboni, Marvin
Sommer,
38
and reactivation)
Jeffrey Cohen
39
Ann Arvin and Allison
40
transmission and epidemiology
Jane Seward and Aisha Jumaan
Part III Pathogenesis, clinical disease, host
response, and epidemiology:
HCMV
Ann Arvin and Richard Whitley
41
consequences
William
42
latency
Michael Jarvis and Jay Nelson
43
Mark Wills, Andrew Carmichael, J. H. Sinclair, and J. G.
Patrick Sissons
44
epidemiology and transmission
Suresh Boppana and Karen Fowler
46
response, and clinical disease
Yasuko Mori and Koichi Yamanishi
47
and reactivation
Kaszuhiro Kondo and Koichi Yamanishi
48
response
Fu-Zhang Wang and Philip Pellet
49
population: epidemiology, transmission
Vincent Emery and Duncan Clark
Part III Pathogenesis, clinical disease, host
response, and epidemiology:
gammaherpesviruses
713
50
KSHV infection
Richard
51
Denis Moss, Scott Burrows, and Rajiv Khanna
52
infection
Dimitrios Lagos and Chris Boshoff
53
with malignant disease
Henrik Hjalgrim,
54
with malignant disease
Jeffrey Martin
55
Nancy Raab-Traub
56
Donald
885
904
915
929
960
986
1007
VIII
Contents
Part IV Non-human primate herpesviruses
Ann Arvin, Patrick Moore, and Richard Whitley
57
Julia Hilliard
58
Ravi Mahalingam and Donald
59
Peter Barry and William Chang
60
Armin Ensser
61
non-human primates
Blossom Damania
Part V Subversion of adaptive immunity
Richard Whitley and Ann Arvin
62
Jatin Vyas, Benjamin
1117
63
immune evasion from antibody and
complement
Lauren Hook and Harvey Friedman
Part VI Antiviral therapy
Richard Whitley
64
David
65
infections
John Gnann, Jr.
66
cytomegalovirus
Paul Griffiths and Michael Boeckh
67
(genomics/proteomics)
Mark Prichard
1211
68
of action and resistance
Karen Biron
Part
Ann Arvin and Koichi Yamanishi
69
George Kemble and Richard Spaete
70
Anne Gershon
71
Thomas Heineman
72
Andrew Morgan and Rajiv Khanna
73 DNA
Thomas Evans and Mary Wloch
74
Ann M.
Rooney
75
delivery
David
Part
1175
76
Frank Tufaro and James
Index
1341
1353
This definitive and comprehensive account of the human
herpesviruses provides an encylopedic overview of their
basic virology and clinical manifestations. This group of
viruses includes human herpes simplex virus type
2.
herpesvirus. cytomegalovirus. varicella-zoster virus, and
human herpesviruses
The diseases they cause are significant and often
recurrent. Their prevalence in the developed world
accounts for a major burden of disease, and as a result
there is a great deal of research into the pathophysiology
of infection and immunobiology.
Another important area covered within this volume
concerns antiviral therapy and the development of
vaccines. All these aspects are covered in depth both
scientifically and in terms of clinical guidelines for
patient care. The text is generously illustrated
throughout and fully referenced to the latest research
and developments. |
any_adam_object | 1 |
any_adam_object_boolean | 1 |
building | Verbundindex |
bvnumber | BV021579848 |
callnumber-first | Q - Science |
callnumber-label | QR201 |
callnumber-raw | QR201.H48 |
callnumber-search | QR201.H48 |
callnumber-sort | QR 3201 H48 |
callnumber-subject | QR - Microbiology |
classification_rvk | XD 7400 |
collection | ebook |
ctrlnum | (OCoLC)170026590 (DE-599)BVBBV021579848 |
dewey-full | 616.9112 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.9112 |
dewey-search | 616.9112 |
dewey-sort | 3616.9112 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
discipline_str_mv | Medizin |
edition | 1. publ. |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01884nam a2200457 c 4500</leader><controlfield tag="001">BV021579848</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20110209 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">060512s2007 ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0521827140</subfield><subfield code="9">0-521-82714-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780521827140</subfield><subfield code="9">978-0-521-82714-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)170026590</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV021579848</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-29</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QR201.H48</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.9112</subfield><subfield code="2">22</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XD 7400</subfield><subfield code="0">(DE-625)152595:13129</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Human herpesviruses</subfield><subfield code="b">biology, therapy, and immunoprophylaxis</subfield><subfield code="c">ed. by Ann Arvin ...</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1. publ.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge [u.a.]</subfield><subfield code="b">Cambridge Univ. Press</subfield><subfield code="c">2007</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XX, 1388 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Maladies à herpèsvirus</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antiviral Agents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Herpesviridae Infections</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Herpesvirus Vaccines</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Herpesvirus diseases</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Herpesviren</subfield><subfield code="0">(DE-588)4159627-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Herpesviren</subfield><subfield code="0">(DE-588)4159627-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Arvin, Ann M.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">http://www.ncbi.nlm.nih.gov/books/NBK47376/</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung UB Regensburg</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014795525&sequence=000003&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung UB Regensburg</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014795525&sequence=000004&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Klappentext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ebook</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-014795525</subfield></datafield></record></collection> |
id | DE-604.BV021579848 |
illustrated | Illustrated |
index_date | 2024-07-02T14:41:21Z |
indexdate | 2024-07-09T20:39:07Z |
institution | BVB |
isbn | 0521827140 9780521827140 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-014795525 |
oclc_num | 170026590 |
open_access_boolean | 1 |
owner | DE-355 DE-BY-UBR DE-29 |
owner_facet | DE-355 DE-BY-UBR DE-29 |
physical | XX, 1388 S. Ill., graph. Darst. |
psigel | ebook |
publishDate | 2007 |
publishDateSearch | 2007 |
publishDateSort | 2007 |
publisher | Cambridge Univ. Press |
record_format | marc |
spelling | Human herpesviruses biology, therapy, and immunoprophylaxis ed. by Ann Arvin ... 1. publ. Cambridge [u.a.] Cambridge Univ. Press 2007 XX, 1388 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Maladies à herpèsvirus Antiviral Agents Herpesviridae Infections Herpesvirus Vaccines Herpesvirus diseases Herpesviren (DE-588)4159627-4 gnd rswk-swf Herpesviren (DE-588)4159627-4 s DE-604 Arvin, Ann M. Sonstige oth http://www.ncbi.nlm.nih.gov/books/NBK47376/ Verlag kostenfrei Volltext Digitalisierung UB Regensburg application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014795525&sequence=000003&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis Digitalisierung UB Regensburg application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014795525&sequence=000004&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA Klappentext |
spellingShingle | Human herpesviruses biology, therapy, and immunoprophylaxis Maladies à herpèsvirus Antiviral Agents Herpesviridae Infections Herpesvirus Vaccines Herpesvirus diseases Herpesviren (DE-588)4159627-4 gnd |
subject_GND | (DE-588)4159627-4 |
title | Human herpesviruses biology, therapy, and immunoprophylaxis |
title_auth | Human herpesviruses biology, therapy, and immunoprophylaxis |
title_exact_search | Human herpesviruses biology, therapy, and immunoprophylaxis |
title_exact_search_txtP | Human herpesviruses biology, therapy, and immunoprophylaxis |
title_full | Human herpesviruses biology, therapy, and immunoprophylaxis ed. by Ann Arvin ... |
title_fullStr | Human herpesviruses biology, therapy, and immunoprophylaxis ed. by Ann Arvin ... |
title_full_unstemmed | Human herpesviruses biology, therapy, and immunoprophylaxis ed. by Ann Arvin ... |
title_short | Human herpesviruses |
title_sort | human herpesviruses biology therapy and immunoprophylaxis |
title_sub | biology, therapy, and immunoprophylaxis |
topic | Maladies à herpèsvirus Antiviral Agents Herpesviridae Infections Herpesvirus Vaccines Herpesvirus diseases Herpesviren (DE-588)4159627-4 gnd |
topic_facet | Maladies à herpèsvirus Antiviral Agents Herpesviridae Infections Herpesvirus Vaccines Herpesvirus diseases Herpesviren |
url | http://www.ncbi.nlm.nih.gov/books/NBK47376/ http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014795525&sequence=000003&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014795525&sequence=000004&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA |
work_keys_str_mv | AT arvinannm humanherpesvirusesbiologytherapyandimmunoprophylaxis |